Your browser doesn't support javascript.
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study.
Garcia-Knight, Miguel; Anglin, Khamal; Tassetto, Michel; Lu, Scott; Zhang, Amethyst; Goldberg, Sarah A; Catching, Adam; Davidson, Michelle C; Shak, Joshua R; Romero, Mariela; Pineda-Ramirez, Jesus; Diaz-Sanchez, Ruth; Rugart, Paulina; Donohue, Kevin; Massachi, Jonathan; Sans, Hannah M; Djomaleu, Manuella; Mathur, Sujata; Servellita, Venice; McIlwain, David; Gaudiliere, Brice; Chen, Jessica; Martinez, Enrique O; Tavs, Jacqueline M; Bronstone, Grace; Weiss, Jacob; Watson, John T; Briggs-Hagen, Melissa; Abedi, Glen R; Rutherford, George W; Deeks, Steven G; Chiu, Charles; Saydah, Sharon; Peluso, Michael J; Midgley, Claire M; Martin, Jeffrey N; Andino, Raul; Kelly, J Daniel.
  • Garcia-Knight M; Department of Microbiology and Immunology, UCSF, California, United States of America.
  • Anglin K; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Tassetto M; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Lu S; Department of Microbiology and Immunology, UCSF, California, United States of America.
  • Zhang A; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Goldberg SA; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Catching A; Department of Microbiology and Immunology, UCSF, California, United States of America.
  • Davidson MC; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Shak JR; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Romero M; Department of Microbiology and Immunology, UCSF, California, United States of America.
  • Pineda-Ramirez J; School of Medicine, University of California, San Francisco, California, United States of America.
  • Diaz-Sanchez R; School of Medicine, University of California, San Francisco, California, United States of America.
  • Rugart P; San Francisco VA Medical Center, San Francisco, California, United States of America.
  • Donohue K; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Massachi J; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Sans HM; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Djomaleu M; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Mathur S; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Servellita V; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • McIlwain D; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Gaudiliere B; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Chen J; School of Medicine, University of California, San Francisco, California, United States of America.
  • Martinez EO; School of Medicine, University of California, San Francisco, California, United States of America.
  • Tavs JM; School of Medicine, University of California, San Francisco, California, United States of America.
  • Bronstone G; School of Medicine, University of California, San Francisco, California, United States of America.
  • Weiss J; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Watson JT; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Briggs-Hagen M; Division of Infectious Diseases, UCSF, California, United States of America.
  • Abedi GR; Department of Microbiology and Immunology, Stanford, California, United States of America.
  • Rutherford GW; Department of Microbiology and Immunology, Stanford, California, United States of America.
  • Deeks SG; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Chiu C; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Saydah S; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Peluso MJ; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Midgley CM; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Martin JN; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
  • Andino R; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
  • Kelly JD; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
PLoS Pathog ; 18(9): e1010802, 2022 09.
Article in English | MEDLINE | ID: covidwho-2021984
ABSTRACT
The impact of vaccination on SARS-CoV-2 infectiousness is not well understood. We compared longitudinal viral shedding dynamics in unvaccinated and fully vaccinated adults. SARS-CoV-2-infected adults were enrolled within 5 days of symptom onset and nasal specimens were self-collected daily for two weeks and intermittently for an additional two weeks. SARS-CoV-2 RNA load and infectious virus were analyzed relative to symptom onset stratified by vaccination status. We tested 1080 nasal specimens from 52 unvaccinated adults enrolled in the pre-Delta period and 32 fully vaccinated adults with predominantly Delta infections. While we observed no differences by vaccination status in maximum RNA levels, maximum infectious titers and the median duration of viral RNA shedding, the rate of decay from the maximum RNA load was faster among vaccinated; maximum infectious titers and maximum RNA levels were highly correlated. Furthermore, amongst participants with infectious virus, median duration of infectious virus detection was reduced from 7.5 days (IQR 6.0-9.0) in unvaccinated participants to 6 days (IQR 5.0-8.0) in those vaccinated (P = 0.02). Accordingly, the odds of shedding infectious virus from days 6 to 12 post-onset were lower among vaccinated participants than unvaccinated participants (OR 0.42 95% CI 0.19-0.89). These results indicate that vaccination had reduced the probability of shedding infectious virus after 5 days from symptom onset.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Humans Language: English Journal: PLoS Pathog Year: 2022 Document Type: Article Affiliation country: Journal.ppat.1010802

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Humans Language: English Journal: PLoS Pathog Year: 2022 Document Type: Article Affiliation country: Journal.ppat.1010802